SPRAVATO®
SPRAVATO® Nasal Esketamine Therapy Now Available
Our psychiatric team has decided to take an important step in the management of treatment-resistant depression. We are offering treatment with SPRAVATO®, a nasal spray, esketamine, specifically designed to address symptoms of depression that have been resistant to other treatments. The treatment is reserved for adults only. Many of our patients have struggled with depression, having tried two or more oral antidepressants without adequate results. For some, traditional treatment methods do not provide the relief needed. This is where SPRAVATO® comes in—it works differently than currently available oral antidepressants.
We believe that adding SPRAVATO® to a current treatment regimen with an oral antidepressant can significantly help alleviate depression symptoms. We are fully certified in the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) program, ensuring that you receive safe, monitored, and effective care. Together, you and your doctor will decide if SPRAVATO® nasal spray, along with an oral antidepressant, may be right for you.
Please call us to schedule an intake appointment; we support your journey toward better mental health. If you’d like more information about SPRAVATO®, please visit Spravato.com to see frequently asked questions.